Leveraging Neoadjuvant and Adjuvant Immunotherapy to Break Through the Outcomes Plateau, Prevent Recurrences, and Improve Curability in Early-Stage Cancers

1.50 hr(s) | ABIM , CME , CPE , MOC , NCPD , Royal College of Physicians and Surgeons of Canada

Specialty: Early-stage Cancers

Therapeutic Area(s): Oncology

Release Date: December 23, 2021

Expiration Date: December 22, 2022

Location: Internet Activity Enduring

In this activity, multidisciplinary oncology experts discuss immunotherapy advances, focusing on transitioning immunotherapies to earlier disease settings to improve outcomes, prevent recurrences, and increase curability in early-stage cancers.

Access this activity
Share via
Copy link
Powered by Social Snap